SUN PHARMA ADVANCED RESEARCH COMPANY
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | |
---|---|---|
EQUITY AND LIABILITIES | ||
Share Capital | ₹32 Cr | ₹32 Cr |
Equity - Authorised | ₹43 Cr | ₹43 Cr |
Equity - Issued | ₹32 Cr | ₹32 Cr |
Equity Paid Up | ₹32 Cr | ₹32 Cr |
Equity Shares Forfeited | - | - |
Adjustments to Equity | - | - |
Preference Capital Paid Up | - | - |
Face Value | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | - | - |
Total Reserves | ₹93 Cr | ₹480 Cr |
Securities Premium | ₹2,038 Cr | ₹2,038 Cr |
Capital Reserves | - | - |
Profit & Loss Account Balance | ₹-1,979 Cr | ₹-1,592 Cr |
General Reserves | ₹34 Cr | ₹34 Cr |
Other Reserves | ₹0.01 Cr | - |
Reserve excluding Revaluation Reserve | ₹93 Cr | ₹480 Cr |
Revaluation reserve | - | - |
Shareholder's Funds | ₹126 Cr | ₹513 Cr |
Minority Interest | - | - |
Long-Term Borrowings | - | - |
Secured Loans | - | - |
Non Convertible Debentures | - | - |
Converible Debentures & Bonds | - | - |
Packing Credit - Bank | - | - |
Inter Corporate & Security Deposit | - | - |
Term Loans - Banks | - | - |
Term Loans - Institutions | - | - |
Other Secured | - | - |
Unsecured Loans | - | - |
Fixed Deposits - Public | - | - |
Loans and advances from subsidiaries | - | - |
Inter Corporate Deposits (Unsecured) | - | - |
Foreign Currency Convertible Notes | - | - |
Long Term Loan in Foreign Currency | - | - |
Loans - Banks | - | - |
Loans - Govt. | - | - |
Loans - Others | - | - |
Other Unsecured Loan | - | - |
Deferred Tax Assets / Liabilities | ₹-1.26 Cr | - |
Deferred Tax Assets | ₹30 Cr | ₹28 Cr |
Deferred Tax Liability | ₹28 Cr | ₹28 Cr |
Other Long Term Liabilities | ₹118 Cr | ₹130 Cr |
Long Term Trade Payables | - | - |
Long Term Provisions | ₹6.05 Cr | ₹8.14 Cr |
Total Non-Current Liabilities | ₹123 Cr | ₹138 Cr |
Current Liabilities | - | - |
Trade Payables | ₹142 Cr | ₹148 Cr |
Sundry Creditors | ₹142 Cr | ₹148 Cr |
Acceptances | - | - |
Due to Subsidiaries- Trade Payables | - | - |
Other Current Liabilities | ₹62 Cr | ₹24 Cr |
Bank Overdraft / Short term credit | - | - |
Advances received from customers | - | ₹0.00 Cr |
Interest Accrued But Not Due | ₹0.07 Cr | - |
Share Application Money | - | ₹0.00 Cr |
Current maturity of Debentures & Bonds | - | - |
Current maturity - Others | - | - |
Other Liabilities | ₹62 Cr | ₹24 Cr |
Short Term Borrowings | ₹47 Cr | ₹0.05 Cr |
Secured ST Loans repayable on Demands | ₹47 Cr | ₹0.05 Cr |
Working Capital Loans- Sec | ₹47 Cr | ₹0.05 Cr |
Buyers Credits - Unsec | - | - |
Commercial Borrowings- Unsec | - | - |
Other Unsecured Loans | ₹-47 Cr | ₹-0.05 Cr |
Short Term Provisions | ₹14 Cr | ₹6.49 Cr |
Proposed Equity Dividend | - | - |
Provision for Corporate Dividend Tax | - | - |
Provision for Tax | ₹1.65 Cr | - |
Provision for post retirement benefits | - | - |
Preference Dividend | - | - |
Other Provisions | ₹12 Cr | ₹6.49 Cr |
Total Current Liabilities | ₹265 Cr | ₹179 Cr |
Total Liabilities | ₹514 Cr | ₹830 Cr |
ASSETS | ||
Gross Block | ₹157 Cr | ₹146 Cr |
Less: Accumulated Depreciation | ₹50 Cr | ₹40 Cr |
Less: Impairment of Assets | - | - |
Net Block | ₹108 Cr | ₹106 Cr |
Lease Adjustment A/c | - | - |
Capital Work in Progress | ₹1.27 Cr | ₹1.87 Cr |
Non Current Investments | - | - |
Long Term Investment | - | - |
Quoted | - | - |
Unquoted | - | - |
Long Term Loans & Advances | ₹68 Cr | ₹65 Cr |
Other Non Current Assets | ₹25 Cr | ₹178 Cr |
Total Non-Current Assets | ₹244 Cr | ₹375 Cr |
Current Assets Loans & Advances | - | - |
Currents Investments | ₹1.80 Cr | ₹291 Cr |
Quoted | ₹1.80 Cr | ₹96 Cr |
Unquoted | - | ₹195 Cr |
Inventories | - | - |
Raw Materials | - | - |
Work-in Progress | - | - |
Finished Goods | - | - |
Packing Materials | - | - |
Stores  and Spare | - | - |
Other Inventory | - | - |
Sundry Debtors | ₹16 Cr | ₹33 Cr |
Debtors more than Six months | ₹6.55 Cr | - |
Debtors Others | ₹11 Cr | ₹33 Cr |
Cash and Bank | ₹155 Cr | ₹112 Cr |
Cash in hand | ₹0.00 Cr | ₹0.00 Cr |
Balances at Bank | ₹155 Cr | ₹112 Cr |
Other cash and bank balances | - | - |
Other Current Assets | ₹42 Cr | ₹3.98 Cr |
Interest accrued on Investments | ₹14 Cr | ₹0.63 Cr |
Interest accrued on Debentures | - | - |
Deposits with Government | - | - |
Interest accrued and or due on loans | - | - |
Prepaid Expenses | ₹4.82 Cr | ₹3.33 Cr |
Other current_assets | ₹23 Cr | ₹0.02 Cr |
Short Term Loans and Advances | ₹54 Cr | ₹16 Cr |
Advances recoverable in cash or in kind | ₹4.35 Cr | ₹4.58 Cr |
Advance income tax and TDS | - | - |
Amounts due from directors | - | - |
Due From Subsidiaries | - | - |
Inter corporate deposits | - | - |
Corporate Deposits | - | - |
Other Loans & Advances | ₹50 Cr | ₹11 Cr |
Total Current Assets | ₹269 Cr | ₹455 Cr |
Net Current Assets (Including Current Investments) | ₹4.33 Cr | ₹276 Cr |
Miscellaneous Expenses not written off | - | - |
Total Assets | ₹514 Cr | ₹830 Cr |
Contingent Liabilities | ₹84 Cr | ₹84 Cr |
Total Debt | ₹47 Cr | ₹0.05 Cr |
Book Value | 3.88 | 15.80 |
Adjusted Book Value | 3.88 | 15.80 |
Compare Balance Sheet of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,865.9 Cr | -1.4% | 33.9% | -61.4% | Stock Analytics | |
SYNGENE INTERNATIONAL | ₹30,053.4 Cr | 3.5% | 14.8% | 2.5% | Stock Analytics | |
SAGILITY INDIA | ₹19,699.0 Cr | -1.1% | 0.3% | NA | Stock Analytics | |
LATENT VIEW ANALYTICS | ₹7,747.8 Cr | 3% | 3.7% | -28.5% | Stock Analytics | |
JUST DIAL | ₹7,097.6 Cr | -1.2% | 5.4% | -2.3% | Stock Analytics | |
AWFIS SPACE SOLUTIONS | ₹4,771.6 Cr | 3% | 4.3% | NA | Stock Analytics |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMA ADVANCED RESEARCH COMPANY | -1.4% |
33.9% |
-61.4% |
SENSEX | -1.3% |
4.2% |
3.6% |
You may also like the below Video Courses